Novo Nordisk A/S Sponsored ADR (NVON)
BMV
Closed
Aug 24, 2026
Day's Range
791.0052 wk Range
637.43Profile - NVON - Novo Nordisk A/S Sponsored ADR
Profile
Mic Code
XMEX
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
78.38K
Novo Nordisk A/S Sponsored ADR is a global healthcare company focused on discovering, developing, manufacturing, and marketing pharmaceutical products. Novo Nordisk A/S Sponsored ADR serves patients and healthcare providers through two main business segments: Diabetes and Obesity Care, which includes therapies for diabetes, obesity, cardiovascular, and related emerging treatment areas, and Rare Disease, which addresses specialized conditions such as rare blood disorders and endocrine disorders. The company offers a broad portfolio of prescription medicines and treatment solutions used in chronic disease management across major international markets. Novo Nordisk A/S Sponsored ADR plays a significant role in the pharmaceutical industry by providing products that support long-term treatment needs in both primary care and specialty care settings.
Profile Details
Type
American Depositary Receipt
Ceo
Mr. Maziar Mike Doustdar
Address
Novo Alle 1
City
Bagsvaerd
Zip
2880
Country
Denmark
Phone
45 44 44 88 88
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
